Capnocytophaga ochracea (formerly Bacteroides ochracea) is a non-sporing, microaerophilic, Gram negative bacillus that may produce a yellow pigment on solid media. It is part of the normal oral flora of humans and causes periodontitis.' 2 Recently, there has been considerable interest in this organism as an opportunistic pathogen in immunosuppressed patients, particularly in the USA.3 We report here two cases of infection, one in a non-compromised host, and review the published work.
Case reports CASE 1 A 50 year old women presented with a 10 day history of a painful submandibular swelling anterior to the right sternomastoid. Pain in the region of the swelling had prevented her eating and she had taken only fluids for the preceding four days. She gave a history of a similar episode occurring seven years previously. Aspiration of the mass at the time had yielded pus, a Gram film of which showed many polymorphonuclear cells and no organisms; it was sterile on culture (incubated for 48 h only). The infection was treated with oral ampicillin and the acute inflammation resolved, leaving a small subcutaneous nodule. Five months before presentation on this occasion she had experienced an episode of pain and swelling in the same region, and this had responded to a course of penicillin V. She gave no history of tuberculosis, diabetes, or any other disease affecting her immunity to infection.
Accepted for publication 13 June 1984 On examination she was apyrexial and had a 5 cm x 4 cm swelling below the angle of the right mandible and anterior to the sternomastoid. The Capnocytophaga ochracea belongs to the class Flexibacteriae, one of three groups of bacteria characterised by their gliding motility on solid surfaces. The genus Capnocytophaga resides within the family Cytophagaceae, which includes species that are common bacteria in soil and water environments. The taxonomy of the gliding bacteria has been comprehensively reviewed,6 as have the characteristics of the genus Capnocytophaga.7 Until recently, the taxonomy of these organisms was rather confused. Two independent reports in 1979, however, established that Capnocytophaga, Bacteroides ochraceus and CDC bio-group DF-1 were synonymous.8 '9 On the basis of biochemical, morphological, and DNA base homology studies'0 Leadbetter and his colleagues proposed that the genus should contain three species: C ochracea, C gingivalis, and C 1068 sputigena." The biochemical criteria for the separation of these three species were also reported by Socransky et al,2 and are compared in the Table. The Table shows that it is difficult to distinguish between the species. Williams and Hammond'0 identified three groups of capnocytophaga using DNA-DNA hybridisation techniques, from which they concluded that there were three distinct species. They found the intergroup divergence greater than expected from the known phenotypic characteristics. Collins et al,'3 however, who examined 13 strains, of which only two or possibly three were used in the DNA-DNA homology studies,"' considered it unlikely that such high interspecies DNA-DNA homology values would occur while the DNA base composition has such a wide range-for example, C gingivalis, DNA-DNA homology range 100-72%,10 has a mol % G+C range of 35-41.
It is interesting that in cases of systemic disease, if the isolate has been speciated it is usually reported as C ochracea. Because of the difficulties outlined above in speciation of Capnocytophaga spp it would be unwise to suggest that C ochracea is more pathogenic than the other species. As further data accumulate on capnocytophaga infections, however, the pathogenicity of the various species should become clearer.
Studies of the antigenic components of Capnocytophaga show that two antigens exist, both probably located in the cell wall.'4 The group specific antigen (G) was found in all 26 strains tested and consists mainly of protein. Three strains also possessed a type specific antigen (T), which was predominantly carbohydrate.'4 In another study of the cell surface components of capnocytophaga all the currently recognised species contained a sulphonolipid unique to the procaryotes, which has been assigned the name capnine. It was suggested that capnine might in some way be related to the gliding motility exhibited by these organisms."3 Capnocytophaga species have also been reported Reports of the occurrence of disease caused by C ochracea in non-immunocompromised patients are rare. C ochracea was reported as the cause of a cervical abscess in a normal adolescent boy in Switzerland.27 A single case of endocarditis caused by C ochracea has also been reported in a nonimmunocompromised patient, which was successfully treated with amoxycillin and metronidazole.28 Recently, a case of septic arthritis of the knee caused by C ochracea was described in a 21 month old child.29 Together with our own case, these are the only reported systemic infections due to this organism in non-neutropenic patients.
The interaction between capnocytophaga and the host defences appears to be complex. It The activity of many third generation cephalosporins was not reported in these studies33 34; it would be of interest as they are increasingly used to treat immunocompromised patients.
Plasmid mediated drug resistance has been reported in C ochracea. Two plasmids were identified; the larger pGD10 (70 megadaltons) specified resistance to chloramphenicol, tetracycline, kanamycin, and streptomycin; the smaller (25 megadaltons) was a cryptic plasmid with no identifiable phenotypic markers.35 Further studies of pDG10 have shown that it belongs to the wide host range incompatibility group FII and has a similar host range to other Inc FII plasmids. Digestion of plasmid DNA from pDG10 with restriction endonucleases showed that it was closely related to other widely distributed R factors such as R100, Rl, and R6.36 In conclusion, members of the genus capnocytophaga are recently recognised pathogens causing oral ulceration in neutropenic patients, which may progress to life threatening septicaemia. They may also cause systemic disease in immunologically normal hosts. The clinical microbiologist should be alerted to the possible presence of this organism if a specimen of pus with an apparently negative Gram film from a site related to the respiratory tract fails to grow a recognisable bacterial pathogen after 48 h incubation.
